Among total 19 individual up-regulated biomarkers belonging to at least one signature, ANXA3 (OS), IL8 (CXCL8) (OS), and CXCL11 (DFS) were associated with the preferred outcome of CRC patients. This evidence concerns the gene ANXA3 and colorectal carcinoma.